Items where Author is "Murphy, Peter"

Naci, Huseyin ORCID: 0000-0002-7192-5751, Shahzad, Mahnum, Murphy, Peter, Zhang, Yichen, Costa, Rebecca, Ross, Joseph S. and Wagner, Anita K. (2025) Costs and benefits of early access to new cancer drugs through the U.S. Food and Drug Administration accelerated approval pathway. BMJ Medicine. ISSN 2754-0413 (In Press)

Naci, Huseyin ORCID: 0000-0002-7192-5751, Murphy, Peter, Woods, Beth, Lomas, James, Wei, Jinru and Papanicolas, Irene ORCID: 0000-0002-8000-3185 (2025) Population health impact of NICE-recommended new drugs – authors' reply. The Lancet, 405 (10497). 2277 - 2278. ISSN 0140-6736

Naci, Huseyin ORCID: 0000-0002-7192-5751, Murphy, Peter, Woods, Beth, Lomas, James, Wei, Jinru and Papanicolas, Irene ORCID: 0000-0002-8000-3185 (2025) Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis. The Lancet, 405 (10472). 50 - 60. ISSN 0140-6736